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Aim: This study was aimed at evaluating the anticancer potential of curcumin-loaded poly(lactic-co-glycolic
acid) (PLGA) based nanoparticles (NPs) in MDA-MB231 human breast cancer cells. Methods: Curcumin-
loaded PLGA NPs were developed using a modified solvent evaporation technique. Physical characteriza-
tion was performed on the formulated NPs. Furthermore, in vitro experiments were conducted to study
the biological activity of the curcumin-loaded NPs. Results: Curcumin-loaded PLGA NPs demonstrated
high encapsulation efficiency and sustained payload release. Moreover, the NPs exhibited a significant
reduction in cell viability, cell migration and cell invasion in the MDA-MB231 cells. Conclusion: The study
revealed that the formulated curcumin-loaded PLGA NPs possessed significant anti-metastatic properties.
The findings showcased the possible potential of curcumin-loaded NPs in the management of debilitating
conditions such as cancer. In addition, this study could form the basis for further research and advance-
ments in this area.
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There has been a renewed interest over medicinal plants in the recent decades. Extensive studies have been
conducted to substantiate the therapeutic potential of pure natural molecules. Many of these potent natural
compounds were targeted to essentially improve the quality of therapeutic regimens against various life-threatening
diseases such as cancer [1,2]. The principles of evolution suggest that one species may produce metabolites that may
be helpful in the survival of another species [1]. Therefore, these metabolites may, potentially, be used as drugs in
the treatment of various diseases. For example, a compound named anagyrine, obtained from Anagyris foetida, is
an endogenous metabolite found in animals [1,3]. It reveals a close resemblance to a nitrogen moiety present in
most neurotransmitters present in animals including humans [3]. This structural resemblance forms the basis to
therapeutically employ anagyrine in neurodegenerative diseases [1]. Co-evolution of various species has rendered
it difficult and complex, to explain the mode of action of such natural compounds as drugs [1]. However, there
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has been a remarkable progress in understanding the mechanisms of action of such natural drugs. Curcumin is a
well-known example of a natural drug which has been used against various diseases such as cancer and inflammation.
Curcumin is a naturally occurring compound which is obtained from the plant, Curcuma longa [4]. Curcumin has
been reported to possess potent therapeutic properties against various pathological conditions and diseases including
cancer, neurological disorders, such as Alzheimer’s disease, Parkinson’s disease and inflammation, mainly due to
its anti-inflammatory and antioxidant nature [5,6]. Recent studies have showed that, curcumin may be helpful in
preventing cancer by affecting the major glycolytic pathways in cancer cells [4].
The knowledge and utilization of nanoparticles (NPs) and nanocarriers have created a paradigm shift in the way
how drugs are delivered to target tissues. Such nanoscale molecules have played a significant role in delivering drug
molecules to various tissues and organs. Delivering curcumin using nanocarriers has demonstrated to be a promising
therapeutic strategy, as it not only delivers the drug to the target site, but also preserves the therapeutic ability of
the loaded drug. In this study, curcumin-loaded NPs were delivered to cancer cells to study their therapeutic ability
as an anticancer agent. Various in vitro assays such as, cell proliferation assay, cell migration assay and cell invasion
assay were performed to assess the effect of curcumin NPs on cancer cells.
Materials & methods
Materials
Poly(lactic-co-glycolic acid) (PLGA) chain terminated polymer (PLA:PGA 50:50, MW 20–30 kDa), curcumin
and methanol were obtained from Sigma Aldrich (Dorset, UK), phosphate-buffered saline (PBS) was procured
from Oxoid (Hampshire, UK). Dulbecco-modified eagle media (DMEM), fetal bovine serum (FBS), penicillin-
streptomycin, optimally reduced serum media, serum-free media and trypsin were procured from Gibco, Life
Technologies (Lancashire, UK). Dimethyl sulfoxide (DMSO) was procured from Tokyo Chemical Industry, (Tokyo,
Japan). Cultrex R© 96 well BME Cell Invasion Assay Kit Cell invasion chamber, 5× BME solution, 10× coating
buffer, 25× cell wash buffer, 10× cell dissociation solution and calcein AM were purchased from R&D systems,
Bio-Techne Ltd. (Oxford, UK). All other chemicals were of analytical grade and obtained from Ulster University
store.
Methods
Payload & its characterization using nuclear magnetic resonance
Curcumin is a natural phytopolyphenol substance extracted from the plant, C. longa, commonly known as
turmeric. The characterization parameters of curcumin-loaded NPs were performed using a proton nuclear magnetic
resonance (NMR) method. The curcumin sample was subjected to NMR study, where a 500 MHz spectrometer
was utilized to produce its NMR spectra. Briefly, 20 mg curcumin was dissolved in 0.5 ml of deuterated CDCl3
(chloroform) and the sample was then processed through a NMR instrument. Samples were analyzed against
trimethylsilyl chloride as an internal standard [7].
Fabrication of the NPs
Curcumin-loaded nanospheres were formulated by a s/o/w (solid-in-oil-in-water) emulsion technique. Briefly,
50 mg of the polymer (PLGA) was dissolved in 2 ml chloroform. An accurately weighed quantity of curcumin
(25 mg) was added to the PLGA/chloroform mixture. The mixture was then sonicated at an energy output of
55 W for 3 min in a Branson Sonifier (model W-350, Branson, CT, USA) to obtain the s/o primary emulsion.
This emulsion was then added to a solution of 20 ml PVA (1.5%) and again sonicated at 55 W for 3 min to form
the final s/o/w emulsion. The final s/o/w emulsion was left overnight in an uncovered condition with stirring.
The mixture was again centrifuged at 13,450 r.p.m. for 15 min to assist the removal of residual solvents. The NPs
thus obtained were washed three times with deionized distilled water. The pellet obtained was then finally dispersed
in 5 ml of deionized distilled water and eventually freeze-dried (Labconco Freeze Dryer, Mason Technology, MO,
USA). The obtained NPs were then stored at room temperature until further use.
Characterization of the formulated NPs – particle size, zeta potential & polydispersity index
The particle size, zeta potential and polydispersity index (PDI) of the formulated NPs were obtained using a
photon correlation spectroscopy (Malvern Zetamaster 500 Malvern Instruments, UK) using a 15 mW laser at an
incident beam of 676 nm as described by Sharma et al.. Briefly, the prepared NPs were filtered through a 0.45 μm
filter. The resultant NPs were then dispersed in 1 ml distilled water to determine the size/PDI. For zeta potential
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measurements, 1 mM potassium chloride solution was used to disperse the loaded NPs. The mixture was then
filtered through a 0.45 μm filter. The filtered NP sample (40 μl) along with 400 μl of distilled water was then filled
in disposable folded capillary cells. The viscosity and other parameters, such as temperature and refraction indices,
were set according to the solvent which was employed to disperse the NPs.
Quantification of payload
Quantification of curcumin was performed using a UV–Vis spectrophotometer (Varian UV vis spectrophotometer,
Mason Technology, NY, USA) via indirect method. Briefly, the supernatant left during the fabrication process of
curcumin NPs was used to determine the encapsulation efficiency. The absorbance was measured at a wavelength of
430 nm (λ max). A standard curve was plotted using 1–9 μg/ml of the sample, which was then used to determine
the encapsulation efficiency.
Release studies
Release studies were carried out to determine the drug release profile of curcumin-loaded NPs. Briefly, 5 mg of
curcumin-loaded NPs were dispersed in 1 ml PBS. The mixture was then incubated under constant end-to-end
rotation at room temperature for 96 h. At each time interval, a sample from dispersed NPs was collected and the
respective absorbance was measured at 430 nm using a microplate reader. A standard graph of known concentration
of curcumin (1–9 μg/ml) was used to determine the concentration of curcumin released from the sample NPs.
Morphology studies – scanning electron microscopy
Morphology of the curcumin-loaded NPs was determined using a scanning electron microscope (SEM). Briefly, an
ultra-thin layer of powdered PLGA–curcumin NPs was applied onto the surface of the metal grid which was later
coated with gold and was left aside for 15 min. The sample was then analyzed using appropriate standard set-up
parameters in the SEM.
In vitro studies
Cell culture & maintenance
We employed the MDA-MB231 breast cancer cell line in our study. Cells were cultured and maintained according
to standard procedures. Briefly, cells were grown in a sterile incubator at 37◦C with 5% CO2. Cells were then
harvested and were allowed to become 80–90% confluent in the growth media. Media was then removed and the
cells were washed with sterile PBS. Later, the cells were trypsinized and transferred to a new flask containing fresh
growth media.
Cell viability assay
Cell viability was determined by an MTT assay, where 4 × 104 MDA-MB231 cells were seeded in a 24-well plate
and later transfected with curcumin-loaded NPs dispersed in the optimal media, using three different concentrations
of curcumin-loaded NPs, in other words, 2.5, 5 and 7.5 μg. Cells were transfected for 24, 48 and 72 h. After
every 24 h, cells washed with PBS and 500 μl of 10% MTT dye in DMEM were added to each well. Cells
were then incubated for 3 h. MTT-containing media was then removed and DMSO was added. The absorbance
was subsequently measured at 570 nm using a micro plate reader (Fluostar Omega Multi-Mode Microplate
Reader, BMG LABTECH Ltd, Aylesbury, UK).
Migration studies: wound scratch assay
Migration of the cells was determined by a wound scratch assay. Briefly, cells were seeded in a 6-well plate and
incubated for 24/48 h until the entire well was confluent. After 24/48 h, a wound was then scratched along the
diameter of the well containing cells using a 200 μl sterile pipette tip. The media was then removed along with the
cells that were floating in the media due to the wound scratch. Then, 2 ml of fresh media along with curcumin
NPs was added to the cells. Cells were also transfected with blank PLGA-NPs and raw curcumin as controls. Cells
were then incubated for 72 h and the image of each well was captured after every 24 h for a total period of 72 h
using a compound microscope. The migration distance was then measured using the ImageJ software.
Invasion studies
Cell invasion assay was performed using a Cultrex R© 96 Well BME Cell Invasion Assay Kit according to manu-
facturer’s instructions. Briefly, the BME membrane was laid in the bottom of the upper chamber and was then
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Figure 1. Proton nuclear magnetic resonance spectra of
curcumin, where, the lower part of the figure was obtained
by a proton NMR, and then was compared with the
estimated curcumin nuclear magnetic resonance (sketched
using ChemDraw software).
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Figure 2. Percentage cumulative release of curcumin from
PLGA–curcumin nanoparticles showing up to 96 h (time intervals
were, 0, 6, 12, 24, 48, 72 and 96 h); 68.13% of curcumin was
released after 96 h.
PLGA: Poly(lactic-co-glycolic acid).
incubated overnight at 37◦C. Later, 50 × 104 cells were seeded and transfected with curcumin-loaded NPs along
with the addition of 150 μl growth media in the bottom chamber wells of the plate. Cells were then incubated
at 37◦C for 24 and 48 h. After 24/48 h, media was aspirated from both upper and lower chamber wells. The
wells were then washed using a washing buffer. Subsequently, the cell dissociation media mixed with calcein-AM
(100 μl) was added to each bottom chamber well to dissociate the invaded cells. The fluorescence of the bottom
chamber was eventually measured at 485 nm (excitation) and 520 nm (emission) wavelength using a microplate
reader (Fluostar Omega Multi-Mode Microplate Reader).
Results
Payload characterization
Curcumin was used as a payload, which was successfully encapsulated in PLGA NPs. The structural stability of
curcumin was determined using a proton NMR (Figure 1). The obtained NMR spectra of curcumin-loaded NPs
revealed a similar pattern as reported by Payton et al. [8]. This confirms the structural intactness of curcumin used
in our experimental studies [8].
Characterization of the NPs
The formulated NPs were characterized using a dynamic light scattering instrument, which was used to determine
the average size and surface charge of PLGA–curcumin NPs [9]. The approximate particle size and PDI of the
loaded NPs were determined to be 188 nm and 0.319, respectively. The approximate zeta potential (surface charge)
was found to be -3.22 mV. The encapsulation efficiency was found to be 79%. Most of the drug was found to be
encapsulated within the NPs with a loss of 21% of the drug.
Release studies
Here, the release property of PLGA–curcumin NPs was assessed. Loaded NPs showed a burst release of 23% after
the first 6 h, later after 24 h the release of the payload was found to be at 43% (Figure 2). After 96 h, nearly 70%
of curcumin was released from the loaded NPs.
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Figure 3. Scanning electron microscope image of
PLGA–curcumin nanoparticles, where, the parameters used
were 20,000 kV; 50,000 magnification; 3 μm scale bar.
PLGA: Poly(lactic-co-glycolic acid).
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Figure 4. Cell viability studies of curcumin-loaded PLGA nanoparticles in MDA-MB231 cell line, where, C1, C2 and C3
were the concentrations of curcumin in the order of 2.5, 5 and 7.5 μg/ml, respectively.
PLGA: Poly(lactic-co-glycolic acid).
Scanning electron microscopy
The morphology of the NPs was assessed using a scanning electron microscope (SEM). The NPs were found to be
spherical and smooth as shown in Figure 3. They appeared to be as rigid, round-shaped nano-structures which was
an important criterion in terms of fabricating loaded NPs.
Cell viability
The cell viability studies were performed using an MTT assay. Cells were transfected with three different concen-
trations (2.5, 5 and 7.5 μg) of curcumin-loaded PLGA NPs. Control cells were transfected with blank PLGA-NPs
and 7.5 μg raw curcumin. Cells were transfected for 24, 48 and 72 h. After 24 h of treatment, the cell viability
of MDA-MB231 cells was decreased to 73% in case of PLGA–curcumin–C1 formulation. The viability decreased
proportionally as the concentration of curcumin increased. Cell viabilities were found to be at 65 and 59% for
PLGA–curcumin–C2 and PLGA–curcumin–C3 formulation respectively (Figure 4). The reduction in cell viability
was due to the burst release of the drug from the NPs which might have killed the cells. Interestingly, raw curcumin
was also found to be toxic to the cells where the cell viability was reduced to 90%. After 48 and 72 h, cell viability had
further decreased. By the end of 72 h, cell viability has reduced to less than 40% in PLGA–curcumin–C1, PLGA–
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curcumin–C2 and PLGA–curcumin–C3 formulations. In addition, the IC50 value was found to be 4.86 μg/m.
In case of raw curcumin, the viability had reduced to 55% after 72 h (Figure 4). Although raw curcumin reduced
the viability of the cells effectively but the extent of reduction in cell viability in case of curcumin-loaded NPs was
considerably higher than that of the raw curcumin. This strengthens the fact that curcumin-loaded NPs were more
effective than the naked drug itself.
Migration studies: wound scratch assay
The cytotoxic action of curcumin was determined by the cell viability study. The anti-metastatic nature of curcumin
was studied by performing a wound scratch assay. Three different concentrations of curcumin NPs were used to
transfect the cells. The migration of the cells was reduced significantly in case of PLGA–curcumin NPs for all the
concentrations studied.
Invasion studies
In our studies, curcumin-loaded NPs were used against MDA-MB231 breast cancer cell line to study the effect
of loaded NPs on cell invasion. Cells were treated with 7.5 μg/ml PLGA–curcumin NPs for 24 and 48 h. In
addition, cells were also transfected with blank PLGA NPs and naked curcumin (7.5 μg/ml). Invasion of the cells
was reduced to 80% and 56% after 24 and 48 h respectively in case of PLGA–curcumin NPs. The extent of cell
invasion was reduced to nearly half after 48 h.
Discussion
PLGA is preferred over other drug delivery derivatives due to its enhanced drug delivery properties. First, unlike
several other derivatives, PLGA is FDA approved which is both biocompatible and biodegradable. This makes
PLGA a safer option for drug delivery in either in vitro or in vivo models as a polymer. Second, due to its user-
friendliness and ease of NP fabrication, PLGA makes the whole fabrication process less complex for the researcher.
Capped PLGA used in the fabrication of the NPs could be the cause for a lower surface charge. In our study,
the charged groups at the ends of PLGA polymer chain was capped, which resulted in a lower zeta potential of
PLGA–curcumin NPs. The recorded observations were close to each other, where mPEG-PLGA polymer was used
to encapsulate curcumin and fabricate the NPs [9].
Payload release from the NPs could either be monophasic or biphasic depending on the type of polymer used [10].
The sustained release property of the payload from NPs is vital to keep the concentration of the payload constant
in the intracellular environment [11]. Khalil et al. carried out the release study of curcumin from PLGA NPs where
the curcumin release was found to be nearly 45% after 96 h which was comparatively less than the release obtained
in our study [12]. This comparatively lesser release of curcumin was probably due to the high molecular weight of
PLGA used by Khalil et al. Higher molecular weights make the corona of the PLGA more rigid, rendering them
less prone to degradation and causing a slow drug diffusion out of the NPs [12].
Poor bioavailability of curcumin has been a long-standing problem [13]. However, with the advent of advanced
formulation techniques, this problem could be overcome by embedding the drug into NPs. Our findings revealed
that the PLGA NPs enhanced the bioavailability of curcumin which resulted in the destruction of more cancer
cells than the raw curcumin [13–15]. In contrast, the blank PLGA NPs caused no cell death. This clearly explains
the nontoxic nature of the PLGA NPs. Similar reduction in cell viability has been reported earlier as well [16]. For
instance, Chuah et al. prepared curcumin-loaded NPs and then delivered those loaded NPs to HT-29 cell line. The
concentrations of curcumin used by Chuah et al. were 10, 20 and 50 μM [14]. In case of curcumin-loaded NPs
(10 μM) the cell viability reduced to 80% after 24 h and on increasing the treatment time from 24 to 48 h and
72 h, cell viability further reduced to 60 and 35%, respectively. In addition, the free curcumin was also found to
reduce the viability of the cells significantly [14,17]. This may be essentially due to the cancer cell-destructing effect
of the free curcumin. Similar findings were reported by Jithan et al. where, curcumin-loaded albumin NPs were
used against MDA-MB231 breast cancer cells to study the cell viability [16]. MDA-MB231 cells were transfected
by 100 μM curcumin for 72 h and the cell viability was reduced to 30%. Whereas, in the case of free curcumin
cell viability was found to be 40% [16]. Cell viability observations obtained by Jithan et al. were in corroboration
with the findings of our study, performed with PLGA–curcumin NPs [16]. Several studies have previously reported
the bioavailability enhancement properties of curcumin-loaded NPs [16]. This in turn has shown to increase the
therapeutic efficacy of curcumin. For instance, Thadakapally et al. encapsulated curcumin in PEG NPs and then
delivered both the loaded NPs and free curcumin to study the effects of these two forms of curcumin on the
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Figure 5. Percentage wound scratch graph of MDA-MB231 breast cancer cells at different time points during
migration studies, where, the first bar represents cells with no treatment, second row represents cells treated
PLGA–blank nanoparticles, and rest of the bars represent curcumin-loaded nanoparticles in various concentrations
(C1, C2 and C3 are 2.5, 5 and 7.5 μg/ml, respectively).
PLGA: Poly(lactic-co-glycolic acid).
viability of MDA-MB231 cell line [17]. Their findings revealed that, the encapsulated curcumin inhibited cell
viability significantly, compared with the free curcumin [17]. Thus, it may be inferred that, the therapeutic potential
of curcumin may be enhanced if delivered along with NPs.
The migration of cancer cells was reduced significantly using curcumin-loaded NPs. On increasing the treatment
duration, the rate of migration of MDA-MB231 cells was reduced greatly as compared with the controls (cells
alone, PLGA-blank NPs and naked curcumin) as shown in Figure 5. Interestingly, from the images which were
captured during the migration studies, it was observed that free curcumin did not contribute significantly towards
affecting the migration of the cells (Figures 6 & 7), as stated by Kumari et al. [18]. Free curcumin, instead, killed
the cells rather than affecting the migration of cells. In contrast, curcumin-loaded NPs slowed down the migration
of the cells effectively.
Cell invasion is another important characteristic feature of cancer cells where they invade a target tissue, colonizing
them and forming secondary tumors. Essentially, it is important to inhibit invasion of the cancer cells to improve
therapeutics against cancer metastasis [19]. The findings from our study support the anti-invasive nature of curcumin.
On the other hand, raw curcumin demonstrated invasion inhibition to 60% after 48 h of treatment (Figure 8).
Although naked curcumin was found to be effective against invasion, but the extent of invasion inhibition was
found to be lesser than loaded NPs. Curcumin-loaded NPs were found to be more effective than naked curcumin.
Chen et al. transfected CL-1 lung adenocarcinoma cells with curcumin in various concentrations and demonstrated
anti-invasion ability of curcumin against CL-1 cells [20]. After 12 h of treatment, cell invasion was inhibited to
65%, when 5 μmol/l curcumin was used [20]. The percentage inhibition of cell invasion observed in this particular
study was higher than the inhibition caused by PLGA–curcumin NPs. This may be due to the high concentration
of curcumin treatment used by Chen et al.. A similar reduction in cancer cell invasion was observed where
10 μM, 20 μM and 30 μM concentrations of curcumin were used as a treatment against human endometrial
adenocarcinoma cells (HEC-1B cells) [21]. After 24 h of transfection, the percentage invasions of cancer cells were
reduced to 80, 50 and 30% when treated with 10, 20 and 30 μM concentrations respectively [21]. Therefore,
we infer that curcumin has demonstrated to be an effective agent against cancer cell migration and metastasis.
Therefore, in our study, we conclude that curcumin has significantly reduced cell invasion [22–24].
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Figure 6. Wound scratch microscopic images of MDA-MB231 breast cancer cells during migration studies, where the
first row represents cells with no treatment, the second row represents cells treated with curcumin and the last row
represents cells transfected with PLGA–blank nanoparticles.
PLGA: Poly(lactic-co-glycolic acid).
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Figure 7. Microscopic image of MDA-MB231 breast cancer cells during migration studies, where the first row
represents the cells loaded with PLGA–curcumin nanoparticles at 0 h and the second row represents cells treated
with curcumin-loaded nanoparticles in different concentrations (C1, C2 and C3 are 2.5, 5 and 7.5 μg/ml, respectively).
PLGA: Poly(lactic-co-glycolic acid).
1770 Nanomedicine (Lond.) (2021) 16(20) future science group
Effects of curcumin-loaded PLGA nanoparticles in MDA-MB231 human breast cancer cells Research Article
24 48
Time (h)
In
va
si
o
n
 (
%
)
0
20
40
60
80
100
120
Cells
PLGA–curcumin NPs
Naked curcumin
PLGA–B
Figure 8. Cell invasion studies of curcumin-loaded nanoparticles on MDA-MB231 breast cancer cell line,
where 7.5 μg/ml of curcumin was used to transfect the cells for 24 and 48 h; cells without treatment, PLGA–blank
nanoparticles and naked curcumin were used as controls.
PLGA: Poly(lactic-co-glycolic acid).
Conclusion
Metastasis is one of the vital characteristics of cancer cells. It is important to control metastasis to improve
therapeutics in cancer treatment [25–27]. Curcumin could be a potent natural substance which can be used against
metastasis. However, the poor solubility and bioavailability of curcumin have been the major drawbacks in using
this drug effectively. NPs have proved to be extremely beneficial in overcoming the challenges posed due to the
poor solubility and bioavailability of curcumin. In our study, curcumin was entrapped inside the PLGA NPs.
These NPs were then delivered to MDA-MB231 breast cancer cells. Physical characterization of curcumin-loaded
NPs showed optimum nano-range size with significant encapsulation efficiency. SEM study revealed smooth,
round morphological features of curcumin loaded PLGA NPs. Moreover, the increased encapsulation efficiency of
curcumin-loaded PLGA NPs and their improved sustained drug release ability may have increased their therapeutic
ability over the previously reported nanosystems. Curcumin was shown to reduce cell viability, cell invasion and
inhibit metastasis when the loaded NPs were delivered to MDA-MB231 cells in vitro. Based on our observations,
we conclude that curcumin is an effective anti-metastatic natural agent.
Future perspective
This study will serve as a platform for newer avenues on the possibility of utilizing curcumin as anti-metastatic
agent in MDA-MB231 breast cancer cells. Furthermore, our findings observed in the aforementioned cells will
form a basis to extend the knowledge of the in-depth biological mechanisms of curcumin in future studies. In
addition, in vivo approaches could be used to further assess the therapeutic impact of curcumin.
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Summary points
• Metastasis of cancer cells is responsible for the high mortality rate in cancer patients worldwide.
• Natural agents such as curcumin may be used as effective therapeutic agents against cancer cells.
• There is an urgent need to develop effective delivery agents which can protect as well as deliver the desired
payload.
• Poly(lactic-co-glycolic acid) based biodegradable nanoparticles (NPs) were fabricated to encapsulate curcumin.
The loaded-NPs exhibited smooth surface morphology and nano-dimensional size.
• Poly(lactic-co-glycolic acid) NPs demonstrated a significant and sustained release of curcumin for up to 96 h.
• Introduction of curcumin-loaded NPs resulted in a significant decrease in cell viability. The reduction in the cell
viability produced by naked curcumin was significantly lesser than loaded-curcumin NPs.
• Curcumin NPs also significantly inhibited metastasis and cell invasion of cancer cells.
• Naked curcumin showed no effect on metastasis and invasion of cells.
• Curcumin NPs proved to be an effective anti-metastatic and anti-invasive agent against MDA-MB231 human
breast cancer cells.
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